A Phase 1 Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Single and Multiple Intravenous Doses of MEDI-546, a Fully Human Monoclonal Antibody directed Against Subunity 1 of the Type I Interferon Alpha Receptor, in Adult Subject
|Effective start/end date||3/12/09 → 9/28/09|
- MedImmune, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.